Top

RACE: A prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for severe aplastic anemia patients

Study number:

8409032

Type of transplant:

Short title:

RACE

Study status:

Deadline for data collection:

Study design:

Open label randomised clinical trial

Primary objective:

To investigate whether Eltrombopag added to standard immunosuppressive treatment increases the rate of early (at three months) complete response in untreated AA patient.

Key inclusion criteria:

≥ 15 years, (very) severe aplastic anemia patients

Country:

France

Germany

Italy

Netherlands

Spain

Switzerland

United Kingdom

Principal investigator:

Antonio Risitano, Regis Peffault de Latour

Principal investigator email:

Study coordinator email:

RACEtrial@lumc.nl